INTERFERON - BETA IgG, MAID

Some Multiple sclerosis patients receiving recombinant interferon-beta (IFNb) develop IFNb-specific antibodies that may block the therapeutic effect of the treatment. This assay screens for IgG antibodies capable of binding to IFNb.

  • Test Type:
  • Pre-test Information:
    Collect sample at least 8 hours after Interferon injection. Provide dose & duration of therapy.
  • Report Delivery:
    Sample by 7th of the month; Report after 2–3 weeks
  • Components:
    0

Sample Report